Shun-Ichiro Ogura

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Prostate Cancer

Respiratory Syndrome Coronavirus

Photodynamic Therapy

Top Venues

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Eriko Nara, Hung Wei Lai, Hideo Imazato, Masahiro Ishizuka, Motowo Nakajima, Shun-Ichiro Ogura
Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro. PloS one 18 (2) (2023)
Eriko Nara, Hung Wei Lai, Hideo Imazato, Masahiro Ishizuka, Motowo Nakajima, Shun-Ichiro Ogura
Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro. PloS one 18 (2) (2023)
Eriko Nara, Hung Wei Lai, Hideo Imazato, Masahiro Ishizuka, Motowo Nakajima, Shun-Ichiro Ogura
Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro. PloS one 18 (2) (2023)
Hung Wei Lai, Moe Kasai, Shinkuro Yamamoto, Hideo Fukuhara, Takashi Karashima, Atsuhi Kurabayashi, Mutsuo Furihata, Kazuhiro Hanazaki, Keiji Inoue, Shun-Ichiro Ogura
Metabolic shift towards oxidative phosphorylation reduces cell density-induced cancer stem cell-like characteristics in prostate cancer in vitro. Biology open (2023)
Eriko Nara, Hung Wei Lai, Hideo Imazato, Masahiro Ishizuka, Motowo Nakajima, Shun-Ichiro Ogura
Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro. PloS one 18 (2) (2023)
Hung Wei Lai, Taku Nakayama, Shun-Ichiro Ogura
Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis. International journal of clinical oncology 26 (1) (2020)
Yuta Sugiyama, Yukari Hiraiwa, Yuichiro Hagiya, Motowo Nakajima, Tohru Tanaka, Shun-Ichiro Ogura
5-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages. BMC immunology 19 (1) (2018)